Arkolith/Insider Trading/LFCR/Form 4

Salus Thomas D.

Chief Legal & AdministrationLIFECORE BIOMEDICAL, INC. \DE\ (LFCR) · full profile →Form 4 · filed Apr 16, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 14, 2025Grant(A)45K——45K
Apr 14, 2025Grant(A)170K——215K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 14, 2025Grant(A)370K—$00
Apr 14, 2025Grant(A)210K—$0210K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001005286-25-000070) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML